# To Evaluate the Adhesion of TK-254RX on Healthy Participants

> **NCT07307794** · PHASE1 · RECRUITING · sponsor: **Teikoku Seiyaku Co., Ltd.** · enrollment: 90 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Esflurbiprofen Topical System

## Key facts

- **NCT ID:** NCT07307794
- **Lead sponsor:** Teikoku Seiyaku Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-19
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07307794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07307794, "To Evaluate the Adhesion of TK-254RX on Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07307794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*